000 01285 a2200313 4500
005 20250518050043.0
264 0 _c20210818
008 202108s 0 0 eng d
022 _a1542-7714
024 7 _a10.1016/j.cgh.2019.05.057
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSripongpun, Pimsiri
245 0 0 _aPotential Benefits of Switching Liver Transplant Recipients to Tenofovir Alafenamide Prophylaxis.
_h[electronic resource]
260 _bClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
_c03 2020
300 _a747-749 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenine
650 0 4 _aAlanine
650 0 4 _aHIV Infections
650 0 4 _aHepatitis B, Chronic
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aLiver Transplantation
650 0 4 _aTenofovir
_xanalogs & derivatives
700 1 _aMannalithara, Ajitha
700 1 _aKwo, Paul Y
700 1 _aKim, W Ray
773 0 _tClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
_gvol. 18
_gno. 3
_gp. 747-749
856 4 0 _uhttps://doi.org/10.1016/j.cgh.2019.05.057
_zAvailable from publisher's website
999 _c29867897
_d29867897